How Is The Tylosin Market Expected To Grow At 5.3% CAGR Over 2025–2029?
Claim 30% Off Global Market Reports With Code ONLINE30 – Insights on Tariff Effects, Global Trade, and Industry Disruptors
What Is The Predicted Market Size Of The Tylosin Industry By 2029?
In the past few years, the tylosin market has exhibited strong growth. Its size expects to surge from $0.74 billion in 2024 to $0.79 billion in 2025, boasting an impressive compound annual growth rate (CAGR) of 5.8%. Various factors contribute to this growth during the historic period, including heightened livestock production, antibiotic growth promoters (AGPs), increased awareness of veterinary health, various government regulations and approvals, and a rise in livestock diseases’ prevalence.
In the coming years, the tylosin market is predicted to experience substantial growth. The market is projected to increase to “$0.96 billion by 2029, with a compound annual growth rate (CAGR) of 5.3%. Reasons for this growth in the forecast period include the increase in global meat consumption, the emphasis on animal health and welfare, the development of livestock farming in developing markets, alterations in regulations, and the prohibition of antibiotic growth promoters. The rise in demand for organic and antibiotic-free meat also contributes. Key trends during this period are expected to include increased demand for alternatives to antibiotics, stricter regulatory policies, advancements in precision livestock farming, expansion in the market for organic and antibiotic-free meat, and improvements in veterinary services and infrastructure.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15946&type=smp
What Drivers Are Accelerating Expansion Of The Tylosin Market?
The tylosin market is set to witness a surge in its growth due to the anticipated increase in meat production. This surge in meat production pertains to the breeding, slaughtering, and processing of animals to provide meat for human use. The rise in meat production is attributed to consumers’ inclination towards nutritious, responsibly sourced food along with concerns about animal welfare and preservation of environment. Tylosin is frequently used as an antibiotic in the livestock sector to manage bacterial infections such as respiratory diseases and issues related to the gastrointestinal tract. It is also utilized as a growth stimulator in certain areas. In February 2024, the Department for Environmental Food and Rural Affairs, a government body based in the UK, announced that the US witnessed a total meat production of 4.2 million tons in 2022 – an increase of 18% from what was recorded ten years ago. Moreover, the production of red meat, chiefly mutton and lamb, increased significantly, registering a growth of 2.9%. Meanwhile, domesticated livestock production showed a slight increase – from 4,178 in 2020 to 4,182 in 2022. Hence, the rising demand for healthful livestock is fuelling the growth of the tylosin market.
Which Segmentation Categories Are Highlighted In The Tylosin Market Analysis?
The tylosin market covered in this report is segmented –
1) By Type: Tylosin Tartrate, Tylosin Phosphate, Other Types
2) By Application: Animal Feed Additives, Animal Drugs, Other Applications
3) By Distribution Channel: Hospital Pharmacies, Drug Stores And Retail Pharmacies, Online Providers
Which Market Trends Are Expected To Define The Future Of The Tylosin Market?
Companies that are significant players in the tylosin market are focusing on developing groundbreaking solutions like tulathromycin injection, aimed at improving treatment possibilities for diseases in livestock. Predominantly, tulathromycin injection acts as an all-encompassing antibiotic in the veterinary sector, being used to combat respiratory and other infections present in livestock. For example, Merck & Co. Inc., a pharmaceutical firm stationed in the US, introduced Tulathromycin injection (Arovyn) in May 2022, with it being accessible in 50, 100, 250, and 500 ml vials. This drug is utilized in treating bovine respiratory disease (BRD), foot rot, and pinkeye conditions in cattle, in addition to respiratory ailments in pigs. It is competent at combating pathogens like Mannheimia haemolytica, Pasteurella multocida, and Moraxella bovis, making tulathromycin a cost-friendly choice for veterinary professionals and livestock producers. It’s necessary to remark that it’s not suitable for administering on female dairy cattle that are 20 months or older, and that it requires an 18-day withdrawal period for cattle and a five-day period for pigs prior to butchering.
Which Players Are Shaping The Competitive Landscape Of The Tylosin Market?
Major companies operating in the tylosin market are Eli Lilly and Company, Zoetis Inc., Elanco Animal Health Inc., Ceva Santé Animale, Apeloa Pharmaceutical co. Ltd., Phibro Animal Health Corporation, Shandong Lukang Pharmaceutical Co. Ltd., Vetoquinol S.A., Norbrook Inc., Qilu Animal Health Products Co. Ltd., Merck & Co. Inc., Hebei Veyong Animal Pharmaceutical, Suanfarma SA, Huvepharma AD, Rochem International Inc., AdvaCare Pharma, Ningxia Tairui Pharmaceutical Co. Ltd., HangZhou Think Chemical Co. Ltd., Vetgen Healthcare Pvt Ltd., Anhui Sinotech Industrial, Pucheng Chia Tai Biochemistry Co Ltd., All Chem Bio Sciences, Nestlife Science Pvt Ltd., Sunvet Pharma Private Ltd., BOC Sciences
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/tylosin-global-market-report
Which Regional Markets Are Emerging As Key Hubs For The Tylosin Market?
North America was the largest region in the tylosin market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tylosin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=15946&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
